Abstract
Kaplan–Meier curves for OS (left column) and PFS (right column), stratified by PET response status (non-responder vs responder), treatment modality (proton vs photon), durvalumab use (durvalumab vs no durvalumab), histology (adenocarcinoma vs squamous cell carcinoma and other), and chemotherapy regimen (carboplatin + paclitaxel vs other).